Sentence examples for supportive long term from inspiring English sources

Europe has different capital markets from the US, and we are fortunate to have supportive long term shareholders including Woodford Investment Management, the Irish Strategic Investment Fund, China Huarong Asset Management, Ballie Gifford and several other city institutions and successful entrepreneurs and family offices, many of whom have active later stage and IPO investment activities.

These difficulties included problems and tensions within supportive long term relationships [ 26, 28, 29, 35, 37].

Mentoring is a supportive, long-term relationship between an experienced mentor and their less experienced mentee.

Most important, I would invest my savings in a supportive, long-term living arrangement, one that I would choose, on my own terms.

LVMH is aiming to be a supportive long-term shareholder of Hermès, and wants to contribute to the preservation of the group's Frenchness and its family-firm attributes.

He believes that universities should be allowed to buy up the debt and then be repaid by students who would, in theory, benefit from a supportive long-term relationship with third-level institutions.

Paul Collins, Brierley's chief executive, says the company is a "supportive long-term shareholder", but many Australian analysts expect Brierley to sell when a profit comes in sight.That may happen in the next few weeks, when the government announces the result of its review of the laws on media ownership.

While Mr. Arnault has said he means to be a supportive long-term shareholder, he has made a career of swallowing up family-owned companies on his way to building LVMH into the largest luxury company in the world, with more than 60 global brands.

Matching residential setting with cognitive and physical abilities is crucial for the provision of a supportive long-term care (LTC) environment.

You may find yourself justifying his or her bad behavior or totally overlooking signs that this person may not make a loving, supportive long-term partner.

With advances in molecular biomarkers that refine and improve risk stratification in patients, those with a high risk of developing bone metastases may benefit from adjuvant or prophylactic treatment with targeted therapeutics, as long as the cytotoxicity is supportive of long term chronic administration.